Pharmaceutical manufacturing is the industrial-scale process of producing medications through chemical synthesis, biotechnology, or extraction, ensuring both quality and regulatory compliance.

“While the recent pitch for domestic manufacturing has hooked a diverse group of players — equipment suppliers, government, academic institutions, nonprofits, specialty manufacturers — global pharma ...

With growing demand for advanced therapies, improved manufacturing processes are needed to provide flexibility and increase ...

The U.S. House of Representatives Committee on Energy and Commerce's Subcommittee on Health held a recent hearing titled "Made in America: Strengthening Domestic Manufacturing and the Health Care ...

WASHINGTON — Purdue University and a coalition of leaders in AI, pharmaceutical manufacturing and public policy on Wednesday (May 7) launched a national effort in the Dirksen Senate Office Building to ...

How CDMOs are reshaping pharmaceutical partnerships through friendshoring, risk-sharing economics, and specialized development capabilities. The pharmaceutical manufacturing landscape is undergoing a ...

What is Real-Time Release Testing? Real-Time Release Testing (RTRT) is an advanced approach to biopharmaceutical manufacturing quality control that improves upon current systems. RTRT is defined as ...

Environmental contamination control is a crucial aspect of sterile pharmaceutical manufacturing, and risk management is needed to guarantee that the necessary control procedures are in place. The risk ...

Autism Research EXPERT Says Trump’s TYLENOL Claims ‘EXTREME’ & ‘DEVASTATING’ | SUNRISE President Trump’s new pharmaceutical ...

State drug control authorities adopt ONDLS for drug licensing, but no State fully complies with CAPA guidelines yet.

Helping pharmaceutical companies increase production efficiency and manage risk more effectively NEW YORK & CHICAGO--(BUSINESS WIRE)--Asahi Kasei Bioprocess America, subsidiary of diversified Japanese ...

GSK plc announced Wednesday that it will invest roughly $1.2B to build a new facility for pharmaceutical manufacturing and research and development in Upper Merion, Pennsylvania, as well as to upgrade ...